IRIS
CIPRANDI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.845
AS - Asia 1.147
EU - Europa 880
SA - Sud America 195
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 4.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.805
CN - Cina 426
SG - Singapore 351
IE - Irlanda 315
HK - Hong Kong 193
BR - Brasile 170
RU - Federazione Russa 158
DE - Germania 121
FI - Finlandia 95
VN - Vietnam 70
IT - Italia 38
SE - Svezia 38
IN - India 33
GB - Regno Unito 32
CA - Canada 25
JP - Giappone 14
PL - Polonia 13
BD - Bangladesh 11
FR - Francia 11
MX - Messico 11
AT - Austria 9
AR - Argentina 8
IQ - Iraq 8
NL - Olanda 8
UA - Ucraina 8
ID - Indonesia 6
BE - Belgio 5
ES - Italia 5
LT - Lituania 5
PK - Pakistan 5
ZA - Sudafrica 5
CO - Colombia 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
KE - Kenya 4
SA - Arabia Saudita 4
TR - Turchia 4
VE - Venezuela 4
CL - Cile 3
EG - Egitto 3
LA - Repubblica Popolare Democratica del Laos 3
BG - Bulgaria 2
CR - Costa Rica 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
JO - Giordania 2
KR - Corea 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
HU - Ungheria 1
IR - Iran 1
LU - Lussemburgo 1
LV - Lettonia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.091
Salva come PNG Salva come JPEG
Città #
Dublin 315
Chandler 271
Dallas 243
Ashburn 212
Hong Kong 193
Singapore 167
Beijing 119
Princeton 66
Boardman 64
Helsinki 61
Lawrence 60
Munich 54
Medford 53
Los Angeles 44
Nanjing 42
Wilmington 40
Shanghai 34
Redondo Beach 32
New York 31
Turku 30
Dong Ket 28
Ann Arbor 24
Nanchang 22
Dearborn 21
Buffalo 20
Changsha 20
São Paulo 19
Washington 19
Moscow 18
The Dalles 17
Hebei 16
Seattle 16
Hangzhou 14
Ho Chi Minh City 14
Jacksonville 14
Tokyo 14
Council Bluffs 12
Hanoi 12
Redwood City 12
Tianjin 12
London 11
Shenyang 11
San Francisco 10
Santa Clara 10
Warsaw 10
Boston 9
Brooklyn 9
Brasília 8
Nuremberg 8
Toronto 8
Atlanta 7
Montreal 7
Pune 7
Stockholm 7
Chicago 6
Fairfield 6
Lyon 6
Phoenix 6
Brussels 5
Cambridge 5
Chennai 5
Columbus 5
Denver 5
Frankfurt am Main 5
Hefei 5
Johannesburg 5
Milan 5
Norwalk 5
Porto Alegre 5
Rio de Janeiro 5
San Jose 5
Amsterdam 4
Berlin 4
Charlotte 4
Falkenstein 4
Houston 4
Kunming 4
Mexico City 4
Orem 4
Poplar 4
Woodbridge 4
Baghdad 3
Campinas 3
Genoa 3
Gunzenhausen 3
Jakarta 3
Jiaxing 3
Jinan 3
Las Vegas 3
Manchester 3
Olomouc 3
Rome 3
Sabzi Mandi 3
Serra 3
Shenzhen 3
São Gonçalo 3
São José dos Campos 3
Wuhan 3
Addis Ababa 2
Ahmedabad 2
Totale 2.781
Salva come PNG Salva come JPEG
Nome #
A polycentric, randomized, double blind, parallel-group, placebo-controlled study on Lertal®, a multicomponent nutraceutical, as add-on treatment in children with allergic rhinoconjunctivitis: phase I during active treatment 129
Allergen-specific immunoglobulin E and allergic rhinitis severity 118
Cross reactivity between recombinant parvalbumin of carp and cod and recombinant grass molecules 117
Adenoids and clinical symptoms: Epidemiology of a cohort of 795 pediatric patients 114
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II 105
Asthma endotyping and biomarkers in childhood asthma 102
Phleum pratense molecular pattern across Italy 96
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares 95
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 92
Low-dose multicomponent medication modulates humoral and cellular immune response in an ex-vivo study on children subjected to adenoid surgery 90
Allergen immunotherapy in children and adolescents with respiratory diseases 88
Biologic Use in Allergic and Asthmatic Children and Adolescents during the COVID-19 Pandemic 85
Anxiety and Depression in Adolescents with Severe Asthma and in Their Parents: Preliminary Results after 1 Year of Treatment 79
Biomarkers of immunotherapy response in patients with allergic rhinitis 78
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 78
Antihistamines in children and adolescents: A practical update 78
Severe asthma in children: Current goals and unmet needs 77
Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management 76
Asthma control in children and adolescents: a study in clinical practice 76
Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View 76
COVID-19 in the pediatric population admitted to a tertiary referral hospital in Northern Italy: Preliminary clinical data 76
Allergen-specific immunoglobulin E and allergic rhinitis severity 73
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma 72
Allergy and Otitis Media in Clinical Practice 71
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study 70
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents 69
Pentraxin 3 and D-dimer in children with asthma: A real-world study 68
Cough Remedies for Children and Adolescents: Current and Future Perspectives 67
Allergen immunotherapy and asthma 66
Immunotherapy and asthma in children 64
Special Issues for Coronavirus Disease 2019 in Children and Adolescents 63
Asthma in children and adolescents: The control’asma project 62
Anxiety and depression in adolescents with asthma and in their parents: A study in clinical practice 61
Personalized therapies for the treatment of allergic rhinitis 57
Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children 56
Complementary treatment of allergic rhinoconjunctivitis: The role of the nutraceutical lertal® 55
Foreword 54
Allergic rhinoconjunctivitis: Pathophysiological mechanism and new therapeutic approach 53
The relevance of symptom perception in the management of severe asthma in adolescents 52
New approaches for identifying and testing potential new anti-asthma agents 51
Tryptophan metabolic pathway and neopterin in asthmatic children in clinical practice 51
The psycho-social effects of COVID-19 on Italian adolescents' attitudes and behaviors 51
Attitude to food supplement use: a survey promoted by the Italian Society of Pediatric Allergy and Immunology 50
What are the effects of rhinitis on patients with asthma? 49
Profiles of birch sensitization (Bet v 1, Bet v 2, and Bet v 4) and oral allergy syndrome across Italy 47
Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach 47
The practical clinical relevance of rhinitis classification in children with asthma: outcomes of the “ControL'Asma” study 46
Focus on the cetirizine use in clinical practice: a reappraisal 30  years later 46
The treatment of allergic rhinitis in asthmatic children and adolescents: practical outcomes from the real-world "ControL'Asma" study 46
Can an otorhinolaryngological visit induce the suspect of allergic rhinitis in children? 45
The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy 44
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study 40
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019 40
Resveratrol: immunological activity and possible application in children and adolescents with allergic rhinitis 40
The Measurement of Asthma and Allergic Rhinitis Control in Children and Adolescents 39
Lertal®, a multicomponent nutraceutical, could reduce the use of antihistamines in children with allergic rhinoconjunctivitis 38
COVID-19 in Italy: The Point of View of the Italian Society of Pediatric Allergy and Immunology-COVID-19 Commission 38
Vitamin D3 in children with allergic asthma in clinical practice 37
The relevance of symptom perception in the management of severe asthma in adolescents 37
Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential Breakthrough 36
Cetirizine use in childhood: An update of a friendly 30-year drug 35
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019 33
Letters to the Editor 31
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 30
Respiratory infections in allergic children: The preventive role of a multicomponent nutraceutical 29
To prevent the allergic disease: The dream of the allergist 29
Thermal water inhalation for allergic rhinitis and recurrent respiratory infections: a narrative review of the evidence 6
Totale 4.169
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 13 5 16 3 8 6 33
2021/2022282 1 2 12 6 10 18 5 17 11 11 41 148
2022/2023819 97 49 6 73 52 85 0 39 376 8 27 7
2023/2024410 44 58 38 38 35 105 20 30 2 25 5 10
2024/20251.017 18 74 30 52 22 52 67 43 242 29 143 245
2025/20261.219 189 158 293 194 288 97 0 0 0 0 0 0
Totale 4.169